Disease-modifying therapies (DMTs) can help reduce the number and severity of multiple sclerosis (MS) relapses. People who stay on their medication are 42% less likely to relapse than those who don’t ...
Effective management of multiple sclerosis (MS) relies heavily on sustained use of disease-modifying therapies (DMTs) to reduce relapse frequency, slow disability progression and preserve quality of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results